Role of streptokinase in management of retained hemothorax: a multicentric study

Authors

  • Ankur Varma Department of Surgery, 151 Base Hospital, Guwahati, Assam, India
  • Ravikant Narain Department of Surgery, 151 Base Hospital, Guwahati, Assam, India
  • Parag Deshmukh Department of Surgery, 151 Base Hospital, Guwahati, Assam, India
  • Himmat Rathore Department of Surgery, 151 Base Hospital, Guwahati, Assam, India
  • S. G. S. Datta Department of Surgery, 151 Base Hospital, Guwahati, Assam, India
  • Aditi V. Varma Department of Radiology, 151 Base Hospital, Guwahati, Assam India
  • Pawan Sharma Department of Trauma Surgery, AFMC, Pune, Maharashtra, India
  • Jebin Joseph Department of Surgery, INHS Sanjeevani, Kochi, Kerala, India

DOI:

https://doi.org/10.18203/2349-2902.isj20204668

Keywords:

Clotted haemothorax, Streptokinase, Fibrinolytic drug

Abstract

Background: Enzymatic debridement of the pleural cavity for retained haemothorax is a frequently overlooked option.

Methods: A retrospective, multicentre study was carried out using intrapleural streptokinase was carried out in 15 patients with retained or clotted haemothorax.

Results: Thirteen of fifteen patients (86%) with retained pleural collections underwent successful enzymatic debridement and tube drainage with streptokinase injections in our study. The average increase in chest tube output following streptokinase injections was 160%. No significant adverse reactions occurred. Two patients required thoracotomy when streptokinase therapy failed. No deaths were reported in the study.

Conclusions: Intrapleural streptokinase is a safe, effective means of removing retained proteinaceous collections in the pleural space. It is a useful adjunct to chest tube drainage and may obviate the need for more invasive procedures.

Author Biography

Ankur Varma, Department of Surgery, 151 Base Hospital, Guwahati, Assam, India

Department of Surgery

151 Base Hospital 

Guwahati , Assam 

India 

References

Navneet S, Damian G, Zubayr Z, Fracs R, Fracs CP. A novel treatment option in the management of traumatic haemothorax. Journal of Trauma and Acute Care Surgery. 2019;86(2):374-5.

Stiles PJ, Drake RM, Helmer SD, Bjordahl PM, Haan JM. Evaluation of chest tube administration of tissue plasminogen activator to treat retained haemothorax. Am J Surg. 2014;207:960-3.

Meyer DM, Jessen ME, Wait MA, Estrera AS. Early evacuation of traumatic retained hemothoraces using thoracoscopy: a prospective, randomized trial. Ann Thorac Surg. 1997;64:1396-400.

Ahmed N, Jones D. Video-assisted thoracic surgery: state of the art in trauma care. Injury. 2004;35:479-89.

Oguzkaya F, Akcali Y, Bilgin M. Video thoracoscopy versus intrapleural streptokinase for management of post traumatic retained haemothorax: a retrospective study of 65 cases. Injury. 2005; 36:526-9.

Navsaria PH, Vogel RJ, Nicol AJ. Thoracoscopic evacuation of retained posttraumatic haemothorax. Ann Thorac Surg. 2004;78:282-5.

Joseph D, Kenji I, Demetrios D, Thomas SM, James C, Jay M et al. AAST Retained Hemothorax Study Group Management of post-traumatic retained haemothorax: A prospective, observational, multicentre AAST study, The Journal of Trauma and Acute Care Surgery. 2012;72(1):316-7

Marder VJ, Sherry. Thrombolytic therapy - current status. N Engl J Med. 1988;318:1512-20.

Thomas TR, Follis F, Kessler RM, Pea SS, Wenly JA. Intrapleural fibrinolysis. Chest. 1996;110:102-6.

Aye RW, Froese DP, Hill LD. Use of purified streptokinase in empyema and haemothorax. Amer J Surg. 1991;161:560-2.

Bergh NP, Ekroth R, Larsson S. Intrapleural streptokinase in the treatment of hemothorax and empyema. Scand J Thor Cardiovasc Surg. 1977;11:265-8.

Stiles PJ, Drake RM, Helmer SD, Bjordahl PM, Haan JM. Evaluation of chest tube administration of tissue plasminogen activator to treat retained hemothorax. Am J Surg. 2014;207:960-3.

Oguzkaya F, Akçali Y, Bilgin M. Videothoracoscopy versus intrapleural streptokinase for management of post traumatic retained haemothorax: A retrospective study of 65 cases. Injury. 2005;36:526-9.

Goehring WO, Grant JJ. Allergic reaction to streptokinase streptodornase solution given intrapleurally. JAMA. 1953; 152: 1429-30.

Cangir AK, Yuksel C, Dakak M. Use of intrapleural streptokinase in experimental minimal clotted hemothorax. Eur J Cardiothorac Surg. 2005;27:667-70.

Rahman NM, Maskell NA, West A. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518-526.

Krasna MJ, Deshmukh S, McLaughlin JS. Complications of thoracoscopy. Ann Thorac Surg. 1996;61:1066-9.

Berglin E, Ekroth R, Teger-Nilsson AC, William-Olsson G. Intrapleural instillation of streptokinase. Effects on systemic fibrinolysis. Thorac Cardiovasc Surg. 1981;29:124-6.

Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998;157:328-30.

Rosen H, Nadkarni V, Theroux M, Padman R, Klein J. Intrapleural streptokinase as adjunctive treatment for persistent empyema in paediatric patients. Chest. 1993;103:1190-3.

Geha AS. Pleural empyema. Changing etiologic, bacteriologic, and therapeutic aspects. J Thorac Cardiovasc Surg. 1971;61:626-35.

Downloads

Published

2020-10-23

Issue

Section

Original Research Articles